Advances in prodrug design
MetadataShow full item record
The background of prodrug design is presented herein as the basis for introducing new and advanced latent systems, taking into account mainly the versatility of polymers and other macromolecules as carriers. PDEPT (Polymer-Directed Enzyme Prodrug Therapy); PELT (Polymer-Enzyme Liposome Therapy); CDS (Chemical Delivery System); ADEPT(Antibody-Directed Enzyme Prodrug Therapy); GDEPT/VDEPT (Gene-Directed Enzyme Prodrug Therapy/Virus-Directed Enzyme Prodrug Therapy); ODDS (Osteotropic Drug Delivery System) and LEAPT (Lectin-directed enzyme-activated prodrug therapy) are briefly described and some examples are given. © 2005 Bentham Science Publishers Ltd.
How to cite this document
Showing items related by title, author, creator and subject.
Nassute, José Carlos ; Longo, Maria do Carmo ; Menegon, Renato Farina; Ribeiro, Yoko Asakura; Chin, Chung Man (Revista de Ciencias Farmaceuticas, 2002) [Artigo]The PDC-70 polymeric prodrug derived from the diclofenac has shown antiedema activity when administered through intramuscular route in rats. Besides that it has produced superior activity when compared to the diclofenac ...
Potential tuberculostatic agents: Micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid Silva, M.; Lara, A. S.; Leite, CQF; Ferreira, E. I. (Archiv Der Pharmazie, 2001) [Artigo]With the objective of obtaining slow-acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle-forming copolymer of poly(ethylene glycol)-poly(aspartic acid) ...
Fernandes, Joao Paulo-dos Santos; Pavan, Fernando Rogério ; Leite, Clarice Queico Fujimura ; Andres Felli, Veni Maria (Saudi Pharmaceutical Journal, 2014) [Artigo]Tuberculosis (TB) is a disease caused mainly by infection of Mycobacterium tuberculosis affecting more than ten million people around the world. Despite TB can be treated, the rise of MDR-TB and XDR-TB cases put the disease ...